Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daniel G. Haller, MD
Abramson Cancer Center at Penn Medicine
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
154 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Porto Alegre Hospital
Porto Alegre, Rio Grande do Sul, Brazil
- Instituto de Oncologia de Soracaba
Sorocaba, São Paulo, Brazil
- Hospital Joao Alves Fiho
Aracaiu-SE, Brazil
- Hospital Socor
Belo Horizonte-MG, Brazil
- Hospital Erastos Gaertner
Curitiba-PR, Brazil
- Instituto Nacional de Cancer
Rio de Janeiro, Brazil
- Oncologistas Associados
Rio de Janeiro, Brazil
- Hospital Do Cancer A C Comargo
São Paulo, Brazil
- Tom Baker Cancer Center - Calgary
Calgary, Alberta, Canada
- University of Alberta
Edmonton, Alberta, Canada
- Nova Scotia Cancer Centre
Halifax, Nova Scotia, Canada
- Royal Victoria Hospital, Barrie
Barrie, Ontario, Canada
- Northeastern Ontario Regional Cancer Centre, Sudbury
Greater Sudbury, Ontario, Canada
- Cancer Care Ontario-London Regional Cancer Centre
London, Ontario, Canada
- Ottawa Regional Cancer Centre
Ottawa, Ontario, Canada
- Mount Sinai Hospital - Toronto
Toronto, Ontario, Canada
- Princess Margaret Hospital
Toronto, Ontario, Canada
- Toronto Sunnybrook Regional Cancer Centre
Toronto, Ontario, Canada
- Hopital Charles Lemoyne
Greenfield Park, Quebec, Canada
- Cite de la Sante de Laval
Laval, Quebec, Canada
- L'Hotel Dieu de Levis
Lévis, Quebec, Canada
- Hopital Du Sacre-Coeur de Montreal
Montreal, Quebec, Canada
- Jewish General Hospital - Montreal
Montreal, Quebec, Canada
- Maisonneuve-Rosemont Hospital
Montreal, Quebec, Canada
- Centre Hospitalier Universitaire de Quebec
Québec, Quebec, Canada
- Centre Hospitalier de L'Universitaire de Quebec, Pavillon Chul
Sainte-Foy, Quebec, Canada
- L'Hopital Laval
Ste-Foy, Quebec, Canada
- Saskatoon Cancer Centre
Saskatoon, Saskatchewan, Canada
- Zoom International Incoporated
Saint Jerome Quebec, Canada
- Charles University Hospital
Hradec Králové, Czechia
- Fakultni Nemocnice V Motole
Prague, Czechia
- Onkologicka Klinka A Onkologicka Lab
Prague, Czechia
- Centre of Clinical Oncology and Radiation Oncology
České Budějovice, Czechia
- Fovarosi Onkormanyzat Szent Margit Korhaz, Okologia
Budapest, Hungary
- Kozponti Honvedkorhaz I. Belgyogyaszat
Budapest, Hungary
- National Institute of Oncology
Budapest, Hungary
- Semmelweis University
Budapest, Hungary
- Szent Laszlo Korhaz
Budapest, Hungary
- Debreceni Egyetem Onkologiai Tanzek
Debrecen, Hungary
- Petz Aladar County Hospital
Gydr, Hungary
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2000
- Primary completion
- —
- Completion
- 31 Oct 2008
- Last update posted
- 19 Dec 2013
- Registered enrollment
- —
- Registry id
- NCT00012389
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.